Maxence Bloch

Maxence Bloch, a partner in Goodwin’s Private Equity Group, focuses his practice on mergers and acquisitions. His experience includes all type of M&A and Private Equity transactions (Mid and Large-cap) with a concentration on MBOs, LBOs, IPOs, public takeovers, build-ups, venture capital and growth capital. He also has a particular expertise in transactions in the life sciences, healthcare, and technology sectors.

Maxence also focuses on litigation matters before all courts relating to M&A transactions, equity financing, and shareholders’ disputes.

Prior to joining Goodwin in 2016, Maxence was a partner at King & Wood Mallesons (formerly SJ Berwin) in Paris. Previously, he practiced at Clifford Chance, where he helped establish its private equity team. Before that, he was a lawyer at Hausmann & Associés and at Thomas & Associés, and was seconded to the Valeo Group for two years.

Maxence’s recent transactions include advising:

• a consortium of new and existing investors comprised of IK Partners, Keensight Capital, Parquest Capital and GIC in the acquisition of the Unither group, a European pharmaceutical contract development and manufacturing organization.
• Cerba Healthcare, a leading player in medical diagnosis:
  • in the carve-out of its veterinary BU, consisting in the sale of Cerba Vet and Antagène, to Mars.
  • in the acquisition of the Labexa group, an independent medical biology group.
  • in the acquisition of the Yourlab group, a clinical pathology group based in Western France.
• Eurazeo in the sale and reinvestment, alongside Towerbrook Capital Partners, in EFESO Management Consultants, a leading international pure player consulting group in industrial operations strategy and performance improvement.
• EW Healthcare Partners in the minority investment in Boiron Développement in order to partially finance the take private of Boiron SA, an independent, family-run pharmaceutical laboratory specializing in the production of very high quality homeopathic medicine.
• IK Partners:
  • in the acquisition of a minority stake in Groupe Octime, a publisher of HR solutions, expert in the management of schedules, working hours and replacements.
  • the founders and the management of the Pinard Emballages group, a manufacturer of plastic bottles intended to serve the cosmetics, fragrance, and personal care markets, in the sale of the group to Bluegem Capital Partners and Arev Partners.
• Oakley Capital in the acquisition of a majority stake in I-Tracing, a provider of cybersecurity consulting and IT security services intended to serve enterprises.
• STS Metals, a supplier of titanium and nickel-based alloys to the aerospace industry, in the acquisition of Brown Europe, a leading European player specializing in the production of wires and bars in alloy steels, stainless steels and superalloys, mainly for the manufacturing of fasteners used in aerospace applications.
• Tikehau Capital, Qualium Investissement, Bpifrance, Geneo Capital and Jolt Capital in the €85 million financing of ChapsVision, a group specialized in the field of investigation and data analysis software in both cyber intelligence and marketing sectors.

Maxence is consistently recognized as a leader in his field by International and French preeminent, peer-reviewed publications:

• Top ranked in Band 1 in Private Equity: Mid-Market in the last edition of the Chambers Europe guide
• Top ranked as Leading Individual in Private Equity: LBO in the last edition of the Legal 500 EMEA guide
• Recommended in Corporate Law, Mergers & Acquisitions Law, and Private Equity Law in the last edition of Best Lawyers France

He was also recognized as valedictorian of Lauréat de l’Ordre des Avocats.

Maxence’s recent publications and speaking engagements include:

Publications

• Author, “L’Europe durcit le contrôle des investissements étrangers," Private Equity Magazine, March 2024
• Author, “Le seuil de 10 % sur le contrôle des investissements étrangers en France pourrait être durablement maintenu," Option Finance, January 2022
• Co-Author (with Céline Domenget-Morin), “Restructuring et Private Equity : maîtriser la nouvelle donne," Capital Finance, March 2020

Speaking Engagements

• Speaker at the conference “LBO : Se projeter dans l’avenir," Les Echos Capital Finance, June 2024
• Speaker at the conference “LBO : Retrouver un nouveau souffle," Les Echos Capital Finance, April 2023
• Speaker at the Roundtable, “Contrôles des investissements étrangers: enjeux et pratiques dans les secteurs stratégiques,” Option Droit & Affaires, January 2023
• Speaker at the conference, “Le LBO, un marché aux nuances infinies?,” Les Echos Capital Finance, February 2022
• Panelist in the session, “Sorties de LBO : quelles bonnes pratiques?,” Les Rencontres Private Equity, Option Finance, March 2020
• Speaker at the conference, “Restructuring et Private Equity : Maîtriser la nouvelle donne,” Les Echos, February 2020
• Speaker at the conference, “Contrôle des investissements étrangers,” Les Echos, November 2018